Asset Management One’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $63.4M | Sell |
141,949
-8,157
| -5% | -$3.8M | 0.19% | 96 |
|
|
2025
Q4 | $69M | Buy |
150,106
+3,242
| +2% | +$1.4M | 0.19% | 96 |
|
|
2025
Q3 | $57.5M | Buy |
146,864
+5,303
| +4% | +$2.22M | 0.17% | 111 |
|
|
2025
Q2 | $63M | Sell |
141,561
-312
| -0.2% | -$144K | 0.2% | 96 |
|
|
2025
Q1 | $68.8M | Buy |
141,873
+6,590
| +5% | +$3.07M | 0.24% | 84 |
|
|
2024
Q4 | $55.3M | Buy |
135,283
+96
| +0.1% | +$44.5K | 0.19% | 99 |
|
|
2024
Q3 | $62.9M | Buy |
135,187
+1,427
| +1% | +$685K | 0.22% | 85 |
|
|
2024
Q2 | $62.7M | Sell |
133,760
-5,049
| -4% | -$2.19M | 0.24% | 79 |
|
|
2024
Q1 | $58M | Sell |
138,809
-3,848
| -3% | -$1.63M | 0.22% | 86 |
|
|
2023
Q4 | $58.4M | Buy |
142,657
+16,559
| +13% | +$6.12M | 0.24% | 85 |
|
|
2023
Q3 | $43.8M | Buy |
126,098
+375
| +0.3% | +$131K | 0.2% | 99 |
|
|
2023
Q2 | $44.2M | Sell |
125,723
-1,190
| -0.9% | -$401K | 0.19% | 103 |
|
|
2023
Q1 | $40M | Buy |
126,913
+7,978
| +7% | +$2.39M | 0.18% | 114 |
|
|
2022
Q4 | $34.4M | Sell |
118,935
-7,130
| -6% | -$2.17M | 0.17% | 127 |
|
|
2022
Q3 | $36.5M | Sell |
126,065
-3,129
| -2% | -$900K | 0.19% | 111 |
|
|
2022
Q2 | $36.4M | Sell |
129,194
-25,819
| -17% | -$6.91M | 0.17% | 124 |
|
|
2022
Q1 | $40.5M | Sell |
155,013
-15,309
| -9% | -$3.63M | 0.16% | 130 |
|
|
2021
Q4 | $38M | Buy |
170,322
+13,382
| +9% | +$2.6M | 0.13% | 152 |
|
|
2021
Q3 | $28.5M | Sell |
156,940
-5,381
| -3% | -$1.05M | 0.11% | 190 |
|
|
2021
Q2 | $32.7M | Buy |
162,321
+4,801
| +3% | +$1M | 0.12% | 174 |
|
|
2021
Q1 | $33.8M | Sell |
157,520
-2,167
| -1% | -$476K | 0.13% | 153 |
|
|
2020
Q4 | $37.3M | Buy |
159,687
+21,644
| +16% | +$4.97M | 0.15% | 135 |
|
|
2020
Q3 | $37.6M | Sell |
138,043
-4,034
| -3% | -$1.11M | 0.17% | 112 |
|
|
2020
Q2 | $41.2M | Buy |
142,077
+970
| +0.7% | +$263K | 0.2% | 99 |
|
|
2020
Q1 | $33.6M | Sell |
141,107
-329
| -0.2% | -$75.5K | 0.2% | 105 |
|
|
2019
Q4 | $31M | Buy |
141,436
+570
| +0.4% | +$115K | 0.14% | 159 |
|
|
2019
Q3 | $23.9M | Buy |
140,866
+3,970
| +3% | +$702K | 0.12% | 198 |
|
|
2019
Q2 | $25.1M | Buy |
136,896
+11,789
| +9% | +$2.06M | 0.12% | 177 |
|
|
2019
Q1 | $23M | Sell |
125,107
-292,016
| -70% | -$53.9M | 0.12% | 170 |
|
|
2018
Q4 | $69M | Buy |
417,123
+1,566
| +0.4% | +$271K | 0.16% | 138 |
|
|
2018
Q3 | $80M | Sell |
415,557
-1,591
| -0.4% | -$283K | 0.16% | 137 |
|
|
2018
Q2 | $70.2M | Buy |
417,148
+22,425
| +6% | +$3.48M | 0.15% | 154 |
|
|
2018
Q1 | $64.3M | Buy |
394,723
+4,966
| +1% | +$811K | 0.14% | 164 |
|
|
2017
Q4 | $58.4M | Sell |
389,757
-1,456
| -0.4% | -$216K | 0.13% | 175 |
|
|
2017
Q3 | $59.4M | Buy |
391,213
+7,896
| +2% | +$1.19M | 0.14% | 164 |
|
|
2017
Q2 | $49.4M | Sell |
383,317
-5,344
| -1% | -$643K | 0.13% | 184 |
|
|
2017
Q1 | $42.5M | Sell |
388,661
-33,569
| -8% | -$2.96M | 0.11% | 212 |
|
|
2016
Q4 | $31.1M | Buy |
422,230
+353,190
| +512% | +$28.7M | 0.08% | 283 |
|
|
2016
Q3 | $5.88M | Sell |
69,040
-2,251
| -3% | -$213K | 0.09% | 259 |
|
|
2016
Q2 | $6.06M | Sell |
71,291
-7,359
| -9% | -$636K | 0.09% | 245 |
|
|
2016
Q1 | $6.17M | Sell |
78,650
-20,373
| -21% | -$1.84M | 0.09% | 249 |
|
|
2015
Q4 | $12.7M | Sell |
99,023
-5,652
| -5% | -$682K | 0.19% | 125 |
|
|
2015
Q3 | $10.5M | Sell |
104,675
-7,979
| -7% | -$1.03M | 0.16% | 148 |
|
|
2015
Q2 | $13.8M | Sell |
112,654
-2,494
| -2% | -$314K | 0.19% | 122 |
|
|
2015
Q1 | $13.9M | Buy |
115,148
+10,244
| +10% | +$1.23M | 0.17% | 140 |
|
|
2014
Q4 | $12.6M | Buy |
104,904
+3,516
| +3% | +$396K | 0.16% | 149 |
|
|
2014
Q3 | $11.5M | Buy |
101,388
+75,072
| +285% | +$7.15M | 0.16% | 146 |
|
|
2014
Q2 | $2.47M | Buy |
26,316
+1,074
| +4% | +$75.3K | 0.04% | 488 |
|
|
2014
Q1 | $1.72M | Sell |
25,242
-11,794
| -32% | -$934K | 0.03% | 568 |
|
|
2013
Q4 | $2.73M | Sell |
37,036
-439
| -1% | -$30.6K | 0.04% | 428 |
|
|
2013
Q3 | $2.85M | Sell |
37,475
-3,356
| -8% | -$267K | 0.04% | 419 |
|
|
2013
Q2 | $3.29M | Buy |
+40,831
| New | +$3.01M | 0.05% | 341 |
|
Other funds holding VRTX
VCM
VPM
Asset Management One's VRTX Position: Q1 2026 in Review
Asset Management One reduced its Vertex Pharmaceuticals (VRTX) stake by 5.4% in Q1 2026, selling an estimated $3.8M and leaving 141,949 shares worth $63.4M. The position accounts for 0.19% of the portfolio, ranked #96.
Asset Management One first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $80M in Q3 2018. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Asset Management One held 141,949 shares of Vertex Pharmaceuticals worth $63.4M as of Q1 2026.
- Asset Management One sold 8,157 Vertex Pharmaceuticals shares in Q1 2026, an estimated $3.8M.
- Vertex Pharmaceuticals made up 0.19% of Asset Management One's portfolio in Q1 2026, its #96 holding.
- Asset Management One first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Asset Management One's Vertex Pharmaceuticals position peaked at $80M in Q3 2018.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Asset Management One's 13F filing for Q1 2026, filed 8 May 2026.